BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 26125644)

  • 21. Gut microbiota, hypertension and chronic kidney disease: Recent advances.
    Sircana A; De Michieli F; Parente R; Framarin L; Leone N; Berrutti M; Paschetta E; Bongiovanni D; Musso G
    Pharmacol Res; 2019 Jun; 144():390-408. PubMed ID: 29378252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Japanese traditional miso soup attenuates salt-induced hypertension and its organ damage in Dahl salt-sensitive rats.
    Yoshinaga M; Toda N; Tamura Y; Terakado S; Ueno M; Otsuka K; Numabe A; Kawabata Y; Uehara Y
    Nutrition; 2012 Sep; 28(9):924-31. PubMed ID: 22261579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Gut Microbiome, Inflammation, and Salt-Sensitive Hypertension.
    Elijovich F; Laffer CL; Sahinoz M; Pitzer A; Ferguson JF; Kirabo A
    Curr Hypertens Rep; 2020 Sep; 22(10):79. PubMed ID: 32880753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between the Gut Microbiota and Blood Pressure in a Population Cohort of 6953 Individuals.
    Palmu J; Salosensaari A; Havulinna AS; Cheng S; Inouye M; Jain M; Salido RA; Sanders K; Brennan C; Humphrey GC; Sanders JG; Vartiainen E; Laatikainen T; Jousilahti P; Salomaa V; Knight R; Lahti L; Niiranen TJ
    J Am Heart Assoc; 2020 Aug; 9(15):e016641. PubMed ID: 32691653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond the gastrointestinal tract: oral and sex-specific skin microbiota are associated with hypertension in rats with genetic disparities.
    Mei X; Mell B; Cheng X; Yeo JY; Yang T; Chiu N; Joe B
    Physiol Genomics; 2022 Jul; 54(7):242-250. PubMed ID: 35503026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissecting the Interplay Mechanism between Epigenetics and Gut Microbiota: Health Maintenance and Disease Prevention.
    Wu Y; Wang CZ; Wan JY; Yao H; Yuan CS
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal Microbiota and Celiac Disease: Cause, Consequence or Co-Evolution?
    Cenit MC; Olivares M; Codoñer-Franch P; Sanz Y
    Nutrients; 2015 Aug; 7(8):6900-23. PubMed ID: 26287240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal arteriolar injury by salt intake contributes to salt memory for the development of hypertension.
    Oguchi H; Sasamura H; Shinoda K; Morita S; Kono H; Nakagawa K; Ishiguro K; Hayashi K; Nakamura M; Azegami T; Oya M; Itoh H
    Hypertension; 2014 Oct; 64(4):784-91. PubMed ID: 24980670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the Gut Microbiome in Obstructive Sleep Apnea-Induced Hypertension.
    Durgan DJ; Ganesh BP; Cope JL; Ajami NJ; Phillips SC; Petrosino JF; Hollister EB; Bryan RM
    Hypertension; 2016 Feb; 67(2):469-74. PubMed ID: 26711739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastrointestinal Tract: a Promising Target for the Management of Hypertension.
    Xiong S; Li Q; Liu D; Zhu Z
    Curr Hypertens Rep; 2017 Apr; 19(4):31. PubMed ID: 28349378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intersection of salt- and immune-mediated mechanisms of hypertension in the gut microbiome.
    Wyatt CM; Crowley SD
    Kidney Int; 2018 Mar; 93(3):532-534. PubMed ID: 29475542
    [No Abstract]   [Full Text] [Related]  

  • 32. The Tasmanian devil microbiome-implications for conservation and management.
    Cheng Y; Fox S; Pemberton D; Hogg C; Papenfuss AT; Belov K
    Microbiome; 2015 Dec; 3():76. PubMed ID: 26689946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Untapped potential of gut microbiome for hypertension management.
    Gao K; Wang PX; Mei X; Yang T; Yu K
    Gut Microbes; 2024; 16(1):2356278. PubMed ID: 38825779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salt, the kidneys, and arterial hypertension.
    Krzesinski JM; Cohen EP
    Acta Clin Belg; 2007; 62(5):348-57. PubMed ID: 18229470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the gut microbiome in sex differences in arterial pressure.
    Beale AL; Kaye DM; Marques FZ
    Biol Sex Differ; 2019 Apr; 10(1):22. PubMed ID: 31023366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral Microbiome and Nitric Oxide: the Missing Link in the Management of Blood Pressure.
    Bryan NS; Tribble G; Angelov N
    Curr Hypertens Rep; 2017 Apr; 19(4):33. PubMed ID: 28353075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Fodor JG; Whitmore B; Leenen F; Larochelle P
    CMAJ; 1999 May; 160(9 Suppl):S29-34. PubMed ID: 10333851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Arguments for a role of the gut microbiota in the pathophysiology of hypertension].
    Huart J; Krzesinski JM; Jouret F
    Rev Med Liege; 2020 Sep; 75(9):588-592. PubMed ID: 32909410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Contribution of Gut Microbiota and Endothelial Dysfunction in the Development of Arterial Hypertension in Animal Models and in Humans.
    Maiuolo J; Carresi C; Gliozzi M; Mollace R; Scarano F; Scicchitano M; Macrì R; Nucera S; Bosco F; Oppedisano F; Ruga S; Coppoletta AR; Guarnieri L; Cardamone A; Bava I; Musolino V; Paone S; Palma E; Mollace V
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.